About this Journal Submit a Manuscript Table of Contents
The Scientific World Journal
Volume 2012 (2012), Article ID 821694, 9 pages
http://dx.doi.org/10.1100/2012/821694
Research Article

Diagnostic Value of Software-Based Image Fusion of Computed Tomography and F18-FDG PET Scans in Patients with Malignant Lymphoma

1Department of Radiology, Medical University Innsbruck, 6020 Innsbruck, Austria
2Department of Nuclear Medicine, Medical University Innsbruck, 6020 Innsbruck, Austria
3Division of Hematology and Oncology, Department of Internal Medicine, Medical University Innsbruck, 6020 Innsbruck, Austria

Received 30 October 2011; Accepted 26 December 2011

Academic Editor: Harry Hendrikse

Copyright © 2012 B. Henninger et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Gossmann, H. T. Eich, A. Engert et al., “CT and MR imaging in Hodgkin's disease—present and future,” European Journal of Haematology, Supplement, vol. 75, no. 66, pp. 83–89, 2005. View at Scopus
  2. R. Bar-Shalom, A. Y. Valdivia, and M. D. Blaufox, “PET imaging in oncology,” Seminars in Nuclear Medicine, vol. 30, no. 3, pp. 150–185, 2000. View at Scopus
  3. A. Giorgetti, D. Volterrani, and G. Mariani, “Clinical oncological applications of positron emission tomography (PET) using fluorine-18-fluoro-2-deoxy-D-glucose,” Radiologia Medica, vol. 103, no. 4, pp. 293–318, 2002. View at Scopus
  4. J. Czernin and M. E. Phelps, “Positron emission tomography scanning: current and future applications,” Annual Review of Medicine, vol. 53, pp. 89–112, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. M. E. Juweid, “Utility of positron emission tomography (PET) scanning in managing patients with Hodgkin lymphoma,” Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, pp. 259–265, 2006. View at Scopus
  6. M. E. Juweid and B. D. Cheson, “Positron-emission tomography and assessment of cancer therapy,” New England Journal of Medicine, vol. 354, no. 5, pp. 496–507, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Jerusalem, Y. Beguin, M. F. Fassotte et al., “Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease,” Haematologica, vol. 86, no. 3, pp. 266–273, 2001. View at Scopus
  8. M. Bangerter, J. Kotzerke, M. Griesshammer, K. Elsner, S. N. Reske, and L. Bergmann, “Positron emission tomography with 18-fluorodeoxyglucose in the staging and follow-up of lymphoma in the chest,” Acta Oncologica, vol. 38, no. 6, pp. 799–804, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. G. K. Von Schulthess, H. C. Steinert, and T. F. Hany, “Integrated PET/CT: current applications and future directions,” Radiology, vol. 238, no. 2, pp. 405–422, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. H. W. D. Yeung, H. Schöder, A. Smith, M. Gonen, and S. M. Larson, “Clinical value of combined positron emission tomography/computed tomography imaging in the interpretation of 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography studies in cancer patients,” Molecular Imaging and Biology, vol. 7, no. 3, pp. 229–235, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. A. J. Lemke, S. M. Niehues, H. Amthauer, T. Rohlfing, N. Hosten, and R. Felix, “Clinical use of digital retrospective image fusion of CT, MRI, FDG-PET and SPECT—fields of indications and results,” RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren, vol. 176, no. 12, pp. 1811–1818, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Nömayr, W. Römer, T. Hothorn et al., “Anatomical accuracy of lesion localization: retrospective interactive rigid image registration between18F-FDG-PET and X-ray CT,” NuklearMedizin, vol. 44, no. 4, pp. 149–155, 2005. View at Scopus
  13. J. O. Armitage, “Staging non-Hodgkin lymphoma,” Ca-A Cancer Journal for Clinicians, vol. 55, no. 6, pp. 368–376, 2005. View at Scopus
  14. P. Lu, “Staging and classification of lymphoma,” Seminars in Nuclear Medicine, vol. 35, no. 3, pp. 160–164, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Dechow, G. Nöldge, M. Libicher, and G. M. Richter, “CT staging of malignant lymphoma. How to avoid misinterpretations,” Radiologe, vol. 42, no. 12, pp. 954–959, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Uffmann and C. Schaefer-Prokop, “Radiological diagnosis of thoracic Hodgkin- and non-Hodgkin lymphomas,” Radiologe, vol. 44, no. 5, pp. 444–456, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. B. D. Cheson, S. J. Horning, B. Coiffier, et al., “Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group,” Journal of Clinical Oncology, vol. 17: 1244, 1999.
  18. R-Development-Core-Team, “A Language and Environment for Statistical Computing,” in R Foundation for Statistical Computing, 2008.
  19. G. Wolz, A. Nömayr, T. Hothorn et al., “Anatomical accuracy of interactive and automated rigid registration between X-ray CT and FDG-PET,” NuklearMedizin, vol. 46, no. 1, pp. 43–48, 2007. View at Scopus
  20. P. J. Slomka, D. Dey, C. Przetak, U. E. Aladl, and R. P. Baum, “Automated 3-Dimensional registration of stand-alone 18F-FDG whole-body PET with CT,” Journal of Nuclear Medicine, vol. 44, no. 7, pp. 1156–1167, 2003. View at Scopus
  21. P. Raanani, Y. Shasha, C. Perry et al., “Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?” Annals of Oncology, vol. 17, no. 1, pp. 117–122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. M. Osman, C. Cohade, E. K. Fishman, and R. L. Wahl, “Clinically significant incidental findings on the unenhanced CT portion of PET/CT studies: frequency in 250 patients,” Journal of Nuclear Medicine, vol. 46, no. 8, pp. 1352–1355, 2005. View at Scopus
  23. H. Schöder, H. W. D. Yeung, and S. M. Larson, “CT in PET/CT: essential features of interpretation,” Journal of Nuclear Medicine, vol. 46, no. 8, pp. 1249–1251, 2005. View at Scopus
  24. A. Bockisch, T. Beyer, G. Antoch et al., “Positron emission tomography/computed tomography-imaging protocols, artifacts, and pitfalls,” Molecular Imaging and Biology, vol. 6, no. 4, pp. 188–199, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. S. Jhanwar and D. J. Straus, “The role of PET in lymphoma,” Journal of Nuclear Medicine, vol. 47, no. 8, pp. 1326–1334, 2006. View at Scopus
  26. G. Jerusalem, R. Hustinx, Y. Beguin, and G. Fillet, “Positron emission tomography imaging for lymphoma,” Current Opinion in Oncology, vol. 17, no. 5, pp. 441–445, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Jerusalem, R. Hustinx, Y. Beguin, and G. Fillet, “Evaluation of therapy for lymphoma,” Seminars in Nuclear Medicine, vol. 35, no. 3, pp. 186–196, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Okada, K. Yoshikawa, K. Imazeki et al., “The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis,” Journal of Nuclear Medicine, vol. 32, no. 4, pp. 686–691, 1991. View at Scopus
  29. J. Okada, K. Yoshikawa, M. Itami et al., “Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity,” Journal of Nuclear Medicine, vol. 33, no. 3, pp. 325–329, 1992. View at Scopus
  30. S. Leskinen-Kallio, U. Ruotsalainen, K. Nagren, M. Teras, and H. Joensuu, “Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study,” Journal of Nuclear Medicine, vol. 32, no. 6, pp. 1211–1218, 1991. View at Scopus
  31. M. Lapela, S. Leskinen, H. R. I. Minn et al., “Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose,” Blood, vol. 86, no. 9, pp. 3522–3527, 1995. View at Scopus
  32. S. F. Barrington and M. J. O'Doherty, “Limitations of PET for imaging lymphoma,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 30, no. 1, pp. S117–S127, 2003. View at Scopus
  33. C. Schiepers, J. E. Filmont, and J. Czernin, “PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 30, no. 1, pp. S82–S88, 2003. View at Scopus
  34. F. Moog, M. Bangerter, C. G. Diederichs et al., “Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging,” Radiology, vol. 203, no. 3, pp. 795–800, 1997. View at Scopus
  35. G. Jerusalem, Y. Beguin, F. Najjar et al., “Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL),” Annals of Oncology, vol. 12, no. 6, pp. 825–830, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. J. S. Newman, I. R. Francis, M. S. Kaminski, and R. L. Wahl, “Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT,” Radiology, vol. 190, no. 1, pp. 111–116, 1994. View at Scopus
  37. F. Najjar, R. Hustinx, G. Jerusalem, G. Fillet, and P. Rigo, “Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL),” Cancer Biotherapy and Radiopharmaceuticals, vol. 16, no. 4, pp. 297–304, 2001. View at Scopus
  38. R. L. Wahl, “Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT,” Journal of Nuclear Medicine, vol. 45, supplement 1, pp. 82S–95S, 2004. View at Scopus
  39. T. Kazama, S. C. Faria, V. Varavithya, S. Phongkitkarun, H. Ito, and H. A. Macapinlac, “FDG PET in the evaluation of treatment for lymphoma: clinical usefulness and pitfalls,” Radiographics, vol. 25, no. 1, pp. 191–207, 2005. View at Scopus
  40. C. La Fougère, W. Hundt, N. Bröckel et al., “Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin's disease and non-Hodgkin's lymphoma,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, no. 12, pp. 1417–1425, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Hernandez-Maraver, F. Hernandez-Navarro, N. Gomez-Leon et al., “Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma,” British Journal of Haematology, vol. 135, no. 3, pp. 293–302, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. L. S. Freudenberg, G. Antoch, P. Schütt et al., “FDG-PET/CT in re-staging of patients with lymphoma,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 31, no. 3, pp. 325–329, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. M. R. Weihrauch, D. Re, S. Bischoff et al., “Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease,” Annals of Hematology, vol. 81, no. 1, pp. 20–25, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. K. D. M. Stumpe, M. Urbinelli, H. C. Steinert, C. Glanzmann, A. Buck, and G. K. Von Schulthess, “Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography,” European Journal of Nuclear Medicine, vol. 25, no. 7, pp. 721–728, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. N. G. Schaefer, T. F. Hany, C. Taverna et al., “Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging—do we need contrast-enhanced CT?” Radiology, vol. 232, no. 3, pp. 823–829, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Tatsumi, C. Cohade, Y. Nakamoto, E. K. Fishman, and R. L. Wahl, “Direct comparison of FDG PET and CT findings in patients with lymphoma: initial experience,” Radiology, vol. 237, no. 3, pp. 1038–1045, 2005. View at Publisher · View at Google Scholar · View at Scopus